Results

Total Results: 2,134 records

Showing results for "discussion".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
    January 01, 2012 - ............................................................................................... 2 Discussion … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussionDiscussion This priority area has a paucity of leads and innovations, despite intensive scanning for … Background Methods Results Discussion
  2. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … See the discussion below. Priority Area 14: Substance Abuse Topic High-Impact Potential 1. … *Community-based opioid overdose prevention program (Project Lazarus) Moderately high Discussion … Results and Discussion of Comments Six experts, with clinical, research, health devices, and health
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/public-reporting-cost-measures_research-protocol.pdf
    January 13, 2014 - Discussion with Key Informants We will discuss with key informants how we plan to identify and synthesize … Field notes will be taken during the key informants’ discussion calls and representatives from AHRQ … answer Guiding Question 2, we will use information learned from our targeted literature review and discussion … This assessment will be informed by findings from the literature searches and discussion with key informants … Agenda for discussion: 1. Introductions and overview of the project 2.
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
    April 25, 2013 - Discussion None Conclusion None Figures None References None Appendix None Source … Discussion The implications of the major findings are clearly stated but the underlying assumptions … Results excluding those trials are noted now in the tables and stated in the discussion. … Page 23, line 27: This discussion focuses on hematologic malignancies. … The discussion was informed by CER results. We acknowledge uncertainties.
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-239-episodic-migraine-comments.pdf
    December 29, 2020 - These limitations were acknowledged in the discussion section of the report. … We have updated the discussion with the following information: “Although only studied in one or a
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-227-noninvasive-nonpharm-chronic-pain-comments.pdf
    April 16, 2020 - Moving forward, we recommend that AHRQ consider a discussion of stratification and treatment matching … We believe that the results and discussion appropriately describes the strenghts and limitations of … We believe that the results and discussion appropriately describes the strenghts and limitations of … In the discussion,w e acknowledge that the inclusion of some interventions would have expanded the … The discussion acknowledges the heterogeneity of what was described as usual care across studies.
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-biopsy_disposition-comments.pdf
    March 11, 2010 - Executive summary Executive summary needs a methods section and a discussion section The template … was revised to include Methods and Discussion sections. … The discussion needs to focus more on the clinical implications of the biopsy approaches. … We have a detailed discussion of the possible impact of the assumption that false- positives do not … Discussion The future research section should be enlarged.
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
    October 12, 2016 - Yes, we agree and have attempted to delineate the limitations in the Discussion chapter, which we have … We have noted this limitation in the Discussion chapter. … We have now added a discussion of this point in the Limitations section of the Discussion. … TEP Reviewer #3 Discussion/Conclusion Yes No response seems to be needed. … of supplemental n-3 FA in the Discussion.
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
    May 27, 2016 - This is fundamental to how we approach any discussion about safety in NHs. … Peer reviewer #5 Findings GQ1c—The discussion on pressure ulcers is insufficient. … They also use the term staffing model but the discussion is very confusing and unclear. … We have moved this discussion and made it more clear why we believe it is important. … The discussion has little to do with nursing homes.
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
    March 01, 2012 - Each proposed research design is accompanied by a discussion of advantages and disadvantages for using … Role of Study Design Considerations Within Future Research Needs The EPCs add a short discussion of … The discussion of study design in the AHRQ FRN documents should be only a first step in developing … The study design terms used in this discussion are listed in Table 1, and descriptions are provided … Such discussion can be useful, however, in illustrating some of the challenges inherent to CER.
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
    November 01, 2016 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments Six experts, with clinical, research, health systems, and health … Executive Summary Background Methods Results Discussion Elagolix for Treatment of Endometriosis … Elagolix for Treatment of Endometriosis Clinical Pathway at Point of This Intervention Results and Discussion
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - ES 2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments Six experts, with clinical, research, health systems, and health … page=all Executive Summary Background Methods Results Discussion Vending Machine Dispensers for … (Plan B One-Step) To Prevent Pregnancy Clinical Pathway at Point of This Intervention Results and Discussion
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
    November 01, 2016 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Elagolix for treatment of endometriosis Lower end of the high-impact-potential range Discussion We … Results and Discussion of Comments Six experts, with clinical, research, health systems, and health … Elagolix for Treatment of Endometriosis Clinical Pathway at Point of This Intervention Results and Discussion
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments Six experts, with clinical, research, and health systems backgrounds … , provided comments on this topics.16-21 We organized the following discussion of expert comments according … Executive Summary Background Methods Results Discussion Off-Label Intranasal Oxytocin (Syntocin)
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1306.pdf
    June 11, 2013 - ES-2 Discussion ................................................................................... … separately), and then topics in the same class of a device, drug, or biologic are aggregated for discussion … Results and Discussion of Comments Six experts, with clinical, research, health systems, and health … page=all Executive Summary Background Methods Results Discussion Vending Machine Dispensers for … (Plan B One-Step) To Prevent Pregnancy Clinical Pathway at Point of This Intervention Results and Discussion
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
    April 01, 2012 - Additional text was added to KQ4a to point to this section for discussion of the OHTS. … Please add a discussion of the applicability of the reviewed studies to the discussion of each key question … Text to this effect has been added to the discussion of KQ3b. … We have added some text to the discussion of KQ3b to address the AGIS. … Peer Reviewer #3 Discussion The discussion discounted the patient-reported outcome of reduced fear
  17. effectivehealthcare-admin.ahrq.gov/products/deliberative-methods/research-2013
    January 01, 2019 - The process includes educational and discussion-based components (i.e., the “information phase” and the … Public deliberation is designed to allow discussion and negotiation concerning complex social issues. … Discussion of approaches to record and summarize deliberative dialogue is very limited in the literature … , as is the discussion of approaches to reporting the results of deliberative activities to the sponsor … The literature presents a comprehensive discussion of the principles of public deliberation, the goals
  18. effectivehealthcare-admin.ahrq.gov/products/pelvic-pain/research-protocol
    December 01, 2020 - After discussion with our TEP following the public posting of the key questions, we further refined the … We also corrected a misalignment between our discussion of outcome measures and our requirement of the … We will note in our discussion of these studies that the results apply to the whole population and should … We will note in our discussion of these studies that the results apply to the whole study population … When extracting data on female subjects only is not possible, we will note in our discussion of these
  19. Slide 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_goalsetting.pdf
    May 18, 2012 - topic & questions • Build facilitation capacity • Connect to decision makers • Plan events • Discussion
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/use_of_handheld_osheroff_respondent.pdf
    January 01, 2009 -  [discussion]   Slide  3:  Handheld  +  4  Other  CDS  Rights   • What  types

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: